Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.

S K Kundu, T. C. Merigan, Lincoln E. Moses et al.|Proceedings of the National Academy of Sciences|1992

Cited by 55